Sharda Cropchem Ltd. · NSE:SHARDACROP

Sharda Cropchem — Q1 FY26 Earnings Presentation

27 slides from Sharda Cropchem's earnings presentation, Jul 25, 2025

  1. Slide 1: Stock exchange filing cover letter

    25th July, 2025 To, National Stock Exchange of India BSE Limited Limited Phiroze Jeejeebhoi Tower, Exchange Plaza, 5th Floor, Plot No. Dalal Street, C/1, Mumbai – 400 001 G-Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Trading Symbol: SHARDACROP Scrip Code: 538666 Subject: Investors / An

  2. Slide 2: Investor Presentation July 2025

    Investor Presentation July 2025 GROWING STRONGER, GOING FURTHER.

  3. Slide 3: Safe Harbor

    SAFE HARBOR This presentation has been prepared by and is the sole responsibility of Sharda Cropchem Limited (the “Company”). By accessing this presentation, you are agreeing to be bound by the trailing restrictions. This presentation does not constitute or form part of any offer or invitation or in

  4. Slide 4: About Sharda Cropchem Limited

    About Sharda Cropchem Limited

  5. Slide 5: Fast-growing global agrochemicals company

    “We are a fast-growing global agrochemicals company with a peer position in the generic crop protection chemicals industry. Our vast and growing library of dossiers and IPRs provide us solid foundations for growth in the global marketplace, especially in Advanced Markets such as Europe, North Americ

  6. Slide 6: Agrochemical Focused Company

    AGROCHEMICAL FOCUSED COMPANY Sharda Cropchem is an Intellectual Property (IP) driven company engaged in marketing and distribution of wide range of formulations and generic active ingredients Asset Light Business Model : Efficiently channelizing time and resources for strengthening core competency o

  7. Slide 7: Asset Light Business Model

    ASSET LIGHT BUSINESS MODEL Overall Agrochemical Value Chain Sharda’s Operating Area √ √ √ √ Basic & Applied Active Ingredient Formulation & Marketing & Identification Registration Research Manufacturing Packaging Distribution Highly flexible operating model Manufacturing of AIs and Focus on identifi

  8. Slide 8: Increasing Global Presence with Widespread Distribution

    INCREASING GLOBAL PRESENCE WITH WIDESPREAD DISTRIBUTION CAPEX incurred in Presence Global Resource Distributors Q1 FY26 80+ countries Deployment 525+ Rs. 114 Cr. across Europe, NAFTA, LATAM & RoW 500+ Over the years, the Company has built a strong brand franchise within our global markets; we are be

  9. Slide 9: The Sharda Advantage

    The Sharda Advantage Healthy Global Reach Wide Product Relationships with Range Suppliers One Stop Solution Quality with Faster Sales Provider for Crop Affordability Service Care Products

  10. Slide 10: Way Forward

    WAY FORWARD 1 2 Forward Integration - Build Sales Force Expand & Strengthen Distribution Presence ✓ Leverage market presence and execution capabilities ✓ Adopt the factory to farmer approach and be a one stop ✓ Expand geographical reach using existing library of dossiers solution provider ✓ Two-fold

  11. Slide 11: Industry Outlook & Growth Drivers

    INDUSTRY OUTLOOK & GROWTH DRIVERS Global crop protection INDUSTRY DRIVERS (In Billion USD) – CAGR of 3.96% A Growing Population: Global population is projected to rise from 7.6 Bn in 2025 141.7 to 8.6 Bn by 2030 and 9.8 Bn by 2050 placing unprecedented pressure on global +3.96% food and protein syst

  12. Slide 12: Experienced Management

    Experienced Management Mr. Ramprakash V. Bubna Mr. Ashish Bubna Mr. Manish Bubna Chairman & Managing Director Whole Time Director Whole Time Director ✓ Holds a Bachelor’s Degree of Technology in Chemical ✓ Holds a Bachelor’s Degree in Commerce from the ✓ Holds a Bachelor’s Degree in Chemical Enginee

  13. Slide 13: Q1 FY26 Financial Highlights

    Q1 FY26 Financial Highlights

  14. Slide 14: Q1 FY26: Segment Wise Highlights

    Q1 FY26: SEGMENT WISE HIGHLIGHTS Cr. Agrochemical Segment Non-Agrochemical Segment TOTAL REVENUES 87% 86% 13% 14% % of Revenue 100% 100% +25% +31% +25% 846 139 985 679 785 106 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 GROWING STRONGER, GOING FURTHER. On Consolidated Basis 13

  15. Slide 15: Q1 FY26: Product Wise Highlights (Agrochemical Segment)

    Q1 FY26: PRODUCT WISE HIGHLIGHTS (Agrochemical Segment) Cr. Herbicides Insecticides Fungicides TOTAL REVENUES (Agrochemical Segment) 47% 50% 23% 24% 31% 26% % of Revenue 100% 100% +32% +7% +25% 420 +34% 222 846 207 205 679 319 153 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 GROWI

  16. Slide 16: Q1 FY26: Region Wise Breakup (Agrochemical Segment)

    Q1 FY26: REGION WISE BREAKUP (Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Agrochemical Segment) 54% 62% 36% 30% +43% +3% +25% 523 249 256 846 364 679 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 LATAM Region RoW 6% 6% 4% 3% +18% -20% 47 26 40 21 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 %

  17. Slide 17: Q1 FY26: Region Wise Breakup (Non-Agrochemical Segment)

    Q1 FY26: REGION WISE BREAKUP (Non - Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Non - Agrochemical Segment) 15% 16% 65% 66% +33% +36% +31% 22 93 139 16 68 106 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 LATAM Region RoW 11% 9% 9% 9% 0% +29% 12 12 12 9 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY25 Q1

  18. Slide 18: Q1 FY26: Financial Highlights

    Q1 FY26 : FINANCIAL HIGHLIGHTS Cr. Revenues & GP Margin EBITDA Profit After Tax 29.2% 35.5% +67% +424% +25% 142 143 985 785 85 27 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 Q1 FY25 Q1 FY26 ✓ Gross Margins have improved 630 basis points to 35.5%. These margins are ✓ Revenue in Q1 FY26 increased by 25% primarily

  19. Slide 19: Strong Balance Sheet

    STRONG BALANCE SHEET Working Capital (in Days) Total Equity 118 days 100 days Rs. 2,649 crores Reduced Working 146 Capital by 18 days (as on 30th June, 2025) 111 107 83 79 87 Rs. 2,501 crores as on Mar’25 Mar-25 Jun-25 Cash, Bank & Liquid Inventory Days Recievable Days Creditor Days Investments RoCE

  20. Slide 20: Annexure

    Annexure

  21. Slide 21: Q1 FY26 Financial Highlights

    Q1 FY26 FINANCIAL HIGHLIGHTS Cr. Particulars Q1 FY26 Q1 FY25 Y-o-Y Revenue from Operations 984.8 785.1 25% COGS 635.6 556.2 Gross Profit 349.2 228.9 53% Gross Margin % 35.5% 29.2% Employee Expenses 14.9 11.2 Other Expenses 192.1 132.4 EBITDA 142.2 85.4 67% EBITDA Margin % 14.4% 10.9% Forex (Gain)/Lo

  22. Slide 22: Key Financial Performance Indices

    KEY FINANCIAL PERFORMANCE INDICES Cr. Revenue EBITDA & EBITDA Margin* Profit After Tax & PAT Margin 19.0% 20.4% 17.6% 10.1% 15.8% 9.6% 9.8% 8.5% 1.0% 7.0% 4,045 4,320 3,580 3,163 729 713 682 349 342 304 2,396 455 229 318 32 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 R

  23. Slide 23: Historical Profit & Loss

    HISTORICAL PROFIT & LOSS Cr. Particulars FY25 FY24 FY23 FY22 FY21 Revenue from Operations 4,319.9 3,163.0 4,045.2 3,579.8 2,395.6 COGS 3,028.1 2,342.4 2,860.8 2,499.8 1,636.0 Gross Profit 1,291.8 820.6 1,184.4 1,080.0 759.7 Gross Margin % 29.9% 25.9% 29.3% 30.2% 31.7% Employee Expenses 52.0 42.4 44.

  24. Slide 24: Balance Sheet – Equity & Liabilities

    BALANCE SHEET – EQUITY & LIABILITIES Cr. Equities & Liabilities FY25 FY24 FY23 FY22 FY21 Shareholder's Funds Equity and Share Capital 90.2 90.2 90.2 90.2 90.2 Other Equity 2,410.4 2,146.9 2,141.8 1,822.2 1,524.1 Non-controlling Interest 0.4 0.4 0.4 0.3 0.3 Total Equity 2,501.0 2,237.5 2,232.4 1,912.

  25. Slide 25: Balance Sheet – Assets

    BALANCE SHEET – ASSETS Cr. ASSETS FY25 FY24 FY23 FY22 FY21 Assets Non-Current Assets Property, Plant and Equipment 3.0 3.8 5.0 14.4 20.9 Right to Use Assets 7.2 14.4 0.0 - - Goodwill 0.0 0.0 0.0 0.0 0.4 Other Intangible assets 740.2 690.0 663.0 577.4 523.1 Intangible assets under development 291.4 2

  26. Slide 26: CSR Activities

    CSR ACTIVITIES CSR initiatives taken up by the Company are in the areas of Promoting Education, Healthcare, Eradicating Hunger, Empowerment of Women, Animal Welfare, Promotion of Sports and Rural Development Projects Promoting Education Animal Welfare Medical Aid & Relief GROWING STRONGER, GOING FUR

  27. Slide 27: Thank You

    GROWING STRONGER, GOING FURTHER. THANK YOU Company: Sharda Cropchem Limited Investor Relation Advisors: Strategic Growth Advisors Pvt. Ltd. CIN: L51909MH2004PLC145007 CIN: U74140MH2010PTC204285 Mr. Shailesh Mehendale – CFO Mr. Deven Dhruva / Ms. Jinal Shah cfo@shardaintl.com / finance@shardaintl.com

Sharda Cropchem — Q1 FY26 Earnings Presentation on 6ix